Nerandomilast Patent Expiration
Nerandomilast was first introduced by Boehringer Ingelheim Pharmaceuticals Inc
Nerandomilast Patents
Given below is the list of patents protecting Nerandomilast, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Jascayd | US11406638 | Oct 22, 2038 | Boehringer Ingelheim | |
| Jascayd | US11813266 | Oct 22, 2038 | Boehringer Ingelheim | |
| Jascayd | US9802954 | Feb 19, 2034 | Boehringer Ingelheim | |
| Jascayd | US8609670 | Aug 23, 2032 | Boehringer Ingelheim | |
| Jascayd | US8754073 | Nov 26, 2029 | Boehringer Ingelheim |
Nerandomilast's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List